C. Marty

发表

Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans*

Kurt Ballmer-Hofer, C. García-echeverría, R. Schwendener, 2003, Journal of Biological Chemistry.

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

R. Schwendener, R. Klemenz, D. Neri, 2002, British Journal of Cancer.

Cytotoxic tumor targeting with scFv antibody-modified liposomes.

R. Schwendener, C. Marty, 2005, Methods in molecular medicine.

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

R. Schwendener, B. Odermatt, K. Ballmer-Hofer, 2006, British Journal of Cancer.

Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes

R. Schwendener, H. Schott, K. Ballmer-Hofer, 2004, Cellular and Molecular Life Sciences CMLS.

Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.

R. Schwendener, R. Klemenz, K. Ballmer-Hofer, 2001, Protein expression and purification.

Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+.

Nikos Agorastos, R. Alberto, P. Haefliger, 2005, Bioconjugate chemistry.

Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy.

R. Schwendener, H. Schott, K. Ballmer-Hofer, 2006, Cancer letters.

Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes

F. Szoka, S. Nir, C. Marty, 2004, Cancer Research.

Targeting human cancer cells with VEGF receptor-2-directed liposomes.

R. Schwendener, R. Jaussi, K. Ballmer-Hofer, 2005, Oncology reports.